Performance analysis of Drugs Made In America Acquisition II (DMII)
Annual Return
Since Dec 3, 2025, DMII has had an average annual return of +2.13%, underperforming the benchmark SPY, which returned +10.33% annual.
| 2026 | 2025 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +1.93% | +0.20% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0.71% | +0.10% | -0.10% | +0.51% | +0.39% | +0% | +0.30% | +1.93% | |||||
| 2025 | +0.20% | +0.20% |
Drawdown analysis of Drugs Made In America Acquisition II (DMII)
The maximum drawdown for the DMII was -0.70%, occurring on Mar 6, 2026. Recovery took 38 trading sessions.
The current DMII drawdown is -0.10%.
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -0.70% | Feb 3, 2026 | 22 | Mar 6, 2026 | 38 | Apr 30, 2026 | 60 |
| -0.50% | Jun 17, 2026 | 6 | Jun 26, 2026 | Ongoing | Ongoing | Ongoing |
| -0.40% | Dec 19, 2025 | 1 | Dec 22, 2025 | 14 | Jan 13, 2026 | 15 |
| -0.20% | Jan 22, 2026 | 2 | Jan 26, 2026 | 6 | Feb 3, 2026 | 8 |
| -0.10% | Dec 3, 2025 | 3 | Dec 8, 2025 | 9 | Dec 19, 2025 | 12 |
| -0.10% | Jan 16, 2026 | 1 | Jan 20, 2026 | 2 | Jan 22, 2026 | 3 |
| -0.10% | Apr 30, 2026 | 3 | May 5, 2026 | 4 | May 11, 2026 | 7 |
| -0.10% | May 26, 2026 | 3 | May 29, 2026 | 5 | Jun 5, 2026 | 8 |
| -0.10% | Jun 9, 2026 | 2 | Jun 11, 2026 | 4 | Jun 17, 2026 | 6 |